THIRUVANANTHAPURAM:
HLL Lifecare Limited has won a research grant of Rs 6.43 crores from the Bill and Melinda Gates Foundation (BMGF) under the Grand Challenges Explorations (GCE) Phase II award for their graphene condom project.
The USD 964,240 (approx Rs 6.43 crores) award, a follow-on to an earlier research grant 
The research team, led by Dr. Lakshminarayanan Ragupathy, had successfully completed the first phase of the study, which involved producing the proto-type of graphene – natural rubber latex nanocomposites based condoms for high heat transfer, improved sensitivity and drug delivery as an approach to increasing the “sexual pleasure and the value of condoms”.
“This second stage investment will be used for the scaling up graphene incorporated Natural Rubber Latex condom production,” said HLL Chairman & Managing Director Dr. M Ayyappan. “The fund will also be utilised for the incorporation of graphene into NRL latex, quality checking, viral penetration test and stability and clinical trials to test the safety and efficacy. HLL is hoping to start the marketing graphene condoms to the entire world including Sub-Saharan African countries, by the end of the phase II,” added Dr. Ayyappan.
Dr. Lakshminarayanan Ragupathy, the Polymer Scientist who was the principal investigator of this project, had earlier received the GCE fund to develop Poly (glycerol sebacate) based condoms in the Grand Challenges Explorations Round 12.
The Grand Challenges Explorations, launched by BMGF, seeks to engage more of world’s innovators to focus on major scientific challenges that will lead to preventing, treating, and curing diseases of the developing world.
more recommended stories
Neuberg Diagnostics Launches ‘Neubee’ – A Digital Health Companion to Simplify Preventive CareMUMBAI:Neuberg Diagnostics, one of India’s leading.
Post-Surgery Brain Development: National Seminar at AmritaKOCHI:Amrita Hospital, Kochi hosted a National.
BuILD Pan-India ILD Digital Registry Launched at Amrita Hospital to Strengthen National ILD CareKOCHI:Interstitial Lung Disease (ILD) is an.
Aster Medcity Kochi Becomes First in India to Launch “Smart” Adaptive DBS for Parkinson’s DiseaseKOCHI:Aster Medcity announced the official launch.
Leading Interventional Pulmonology Conference in Asia to be Held in KochiKOCHI:One of Asia’s prominent conferences in.
National Seminar at Amrita Hospital to Focus on Post-Surgery Brain Development in ChildrenKOCHI:Amrita Hospital, Kochi, will host a.
Craft Fertility and Nova IVF Announce Strategic Partnership to Open 10 IVF Centres Across KeralaKOCHI:Craft Fertility Centre, Kerala’s most trusted.
Kerala’s First Biodegradable Airway Stenting: A Milestone Achievement for Amrita HospitalKOCHI:Amrita Hospital, Kochi, has achieved a.
Advancing Diabetic Foot Care: A Successful CME at Amrita HospitalKOCHI:The Department of Endocrinology & Diabetic.
Rare Genetic Disorder: 5-Year-Old Maldivian Child Makes Miraculous Recovery at Amrita HospitalKOCHI:A five-year-old Maldivian boy has returned.
Leave a Comment